We are live on ! Find out more
PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+20.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$133M
AUM Growth
-$17.8M
Cap. Flow
-$9.9M
Cap. Flow %
-7.46%
Top 10 Hldgs %
46.17%
Holding
130
New
18
Increased
25
Reduced
65
Closed
22

Top Buys

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$3.84M
2
SAGE
Sage Therapeutics
SAGE
+$2.55M
3
NAII icon
Natural Alternatives International
NAII
+$1.88M
4
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.85M
5
LHCG
LHC Group LLC
LHCG
+$1.62M

Top Sells

Rank Stock Value
1
KTEC
Key Technology Inc
KTEC
+$11.2M
2
AERI
Aerie Pharmaceuticals
AERI
+$4.12M
3
PFPT
Proofpoint, Inc.
PFPT
+$3.65M
4
ABCB icon
Ameris Bancorp
ABCB
+$3.13M
5
ISBC
Investors Bancorp, Inc.
ISBC
+$2.81M

Sector Composition

Rank Sector Weight
1 Industrials 15.96%
2 Healthcare 13.66%
3 Technology 11.8%
4 Consumer Staples 6.96%
5 Financials 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTLA
126
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-7,309
Closed -$356K
MBFI
127
DELISTED
MB Financial Corp
MBFI
– –
-12,020
Closed -$536K
NTRI
128
DELISTED
NutriSystem, Inc.
NTRI
– –
-8,748
Closed -$459K
SYNT
129
DELISTED
Syntel Inc
SYNT
– –
-10,519
Closed -$242K
KTEC
130
DELISTED
Key Technology Inc
KTEC
– –
-608,125
Closed -$11.2M
2 3 4 5
6

Similar funds

CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
QI
Quilter Investors London, United Kingdom $22.3M AUM 6.63% 1-Year Est. Return
HWM
Highwater Wealth Management Glendale, Colorado $22.6M AUM 3.46% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
MAU
MRA Associates USA Phoenix, Arizona $25.4M AUM 0.38% 1-Year Est. Return
FCG
FrontFour Capital Group Greenwich, Connecticut $26.5M AUM 17.69% 1-Year Est. Return

Pacific View Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Pacific View Asset Management held 130 positions worth $133M, down 12% from $151M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Pacific View Asset Management withdrew a net $9.9M in Q1 2018, closing 22 positions and reducing 65 holdings. Its most notable exit was Key Technology Inc, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Pacific View Asset Management opened a new position in Aimmune Therapeutics worth $3.47M.

  • Pacific View Asset Management's largest Q1 2018 buy was Aimmune Therapeutics: 108,984 shares worth $3.47M.
  • Pacific View Asset Management added most to Sage Therapeutics in Q1 2018, an estimated $2.55M increase.
  • Pacific View Asset Management's biggest Q1 2018 reduction was Aerie Pharmaceuticals, cutting an estimated $4.12M.
  • Pacific View Asset Management fully exited Key Technology Inc in Q1 2018, selling an estimated $11.2M.
  • Pacific View Asset Management's ten largest holdings make up 46% of its $133M portfolio in Q1 2018.
  • Pacific View Asset Management opened 18 new positions and closed 22 in Q1 2018.
  • Pacific View Asset Management's portfolio value fell 12% quarter-over-quarter to $133M.

Based on Pacific View Asset Management's 13F filing for Q1 2018, filed 15 May 2018.